CUSIP 697947109COMPVLAQ4 2025
14 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Suvretta Capital Management, LLC | 892.4K | $93.41M |
| 2 | Bvf Inc/Il | 879.0K | $92.01M |
| 3 | Frazier Life Sciences Management, L.P. | 722.4K | $75.61M |
| 4 | First Light Asset Management, LLC | 709.1K | $74.23M |
| 5 | Vanguard Group Inc | 560.6K | $58.68M |
| 6 | Blackrock, Inc. | 559.1K | $58.52M |
| 7 | State Street Corp | 420.5K | $44.01M |
| 8 | Summit Partners Public Asset Management, LLC | 389.4K | $40.76M |
| 9 |
| 4 | Nov 14, 2025 | Biotechnology Value Fund L P | 13G/A | 10.0% | 1.18M | SEC |
| 5 | Nov 13, 2025 | Suvretta Capital Management, LLC | 13G/A | 7.4% | 822.4K | SEC |
| 6 | Aug 14, 2025 | Samsara Biocapital, L.P. | 13G/A | 3.1% | 339.7K | SEC |
| 7 | Aug 14, 2025 | Frazier Life Sciences Public Fund, L.P. | 13G/A | 4.9% | 545.5K | SEC |
| 8 | May 15, 2025 | Frazier Life Sciences Public Fund, L.P. | 13G/A | 6.3% | 690.0K | SEC |
| 9 | Jan 8, 2025 | Frazier Life Sciences Public Fund, L.P. | 13G | 11.0% | 575.9K | SEC |
| 10 | Dec 20, 2024 | Kaupinen Wes | 13D | 14.6% | — | SEC |
See the full Schedule 13D/13G history for Palvella Therapeutics Inc Ne.
Unlock full history| Jennison Associates LLC |
| 387.5K |
| $40.56M |
| 10 | Federated Hermes, Inc. | 368.0K | $38.52M |